Cover Image
市場調查報告書

亞斯伯格症候群:全球臨床實驗趨勢

Asperger Syndrome Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 172335
出版日期 內容資訊 英文 53 Pages
訂單完成後即時交付
價格
Back to Top
亞斯伯格症候群:全球臨床實驗趨勢 Asperger Syndrome Global Clinical Trials Review, H1, 2017
出版日期: 2017年04月26日 內容資訊: 英文 53 Pages
簡介

本報告提供亞斯伯格症候群治療藥相關臨床實驗的最新趨勢分析,提供G7 (主要7國) 各國及E7 (新興7國) 的臨床實驗數量,受驗人數,有潛力的贊助商,參與臨床實驗的主要企業和機關,有潛力的藥劑等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗中亞斯伯格症候群的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

亞斯伯格症候群治療藥臨床實驗參與的主要企業

有潛力的藥劑

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Asperger Syndrome Global Clinical Trials Review, H1, 2017" provides an overview of Asperger Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Asperger Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Asperger Syndrome to Central Nervous System Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by Phase 19
  • In Progress Trials by Phase 20
  • Clinical Trials by Trial Status 21
  • Clinical Trials by End Point Status 22
  • Subjects Recruited Over a Period of Time 23
  • Clinical Trials by Sponsor Type 24
  • Prominent Sponsors 25
  • Top Companies Participating in Asperger Syndrome Therapeutics Clinical Trials 27
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 51

  • Abbreviations 51
  • Definitions 51
  • Research Methodology 52
  • Secondary Research 52
  • About GlobalData 53
  • Contact Us 53
  • Source 53

List of Tables

List of Tables

  • Asperger Syndrome Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Asperger Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Asperger Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Asperger Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Asperger Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Asperger Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Asperger Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Asperger Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
  • Proportion of Asperger Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 16
  • Asperger Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Asperger Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Asperger Syndrome Therapeutics, Global, Clinical Trials by Phase, 2017* 19
  • Asperger Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20
  • Asperger Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
  • Asperger Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
  • Asperger Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
  • Asperger Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24
  • Asperger Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Asperger Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Asperger Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures

List of Figures

  • Asperger Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Asperger Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Asperger Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Asperger Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
  • Asperger Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Asperger Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Proportion of Asperger Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
  • Asperger Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Asperger Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Asperger Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
  • Asperger Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20
  • Asperger Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
  • Asperger Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
  • Asperger Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
  • Asperger Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24
  • Asperger Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Asperger Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Asperger Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
  • GlobalData Methodology 52
Back to Top